Posts

Introducing a New Selective Medium: Cefixime-Tellurite-...

In a groundbreaking study carried out by researchers at Osaka Metropolitan Unive...

KIST Unveils Cutting-Edge Full-Color Upconversion Nanop...

Revolutionizing Display Technology with Advanced Upconversion Nanoparticles In a...

Unveiling the Twist: Light-Induced Reversal of Supramol...

In an intriguing advance in the field of molecular science, researchers from Chi...

Engineered Bacteria Emit Detectable Signals from Afar

Bacteria, highly adaptable organisms known for their versatility in various envi...

Breakthrough RNA Blood Test Enables Early Detection of ...

Researchers at the Hebrew University of Jerusalem have pioneered a groundbreakin...

Revolutionary Scalable Graphene Membranes: A Breakthrou...

In the ongoing battle against climate change, capturing carbon dioxide (CO₂) emi...

Novo Nordisk outlays $1.09bn to boost GLP-1RA productio...

Novo Nordisk continues its sizeable manufacturing investments to meet increasing...

US to impose tariffs on pharmaceutical imports

US President Donald Trump has stated that the country is set to announce “major ...

AbbVie’s upadacitinib gains EU marketing authorisation ...

The EC has granted marketing authorisation for AbbVie's once-a-day treatment Rin...

FDA approves injectable antibiotics for B Braun drug de...

The FDA has granted approval for the injectable antibiotic, Piperacillin and Taz...

Merida launches with $121m to target autoimmune antibodies

The funding will be used to advance Merida’s lead programme in the autoimmune co...

IRA holds the scope to shape pharma’s research strategy...

The Inflation Reduction Act (IRA) is expected to influence the clinical developm...

Beyond oncology: The expanding potential of cell and ge...

The potential for cell and gene therapies is growing, offering groundbreaking tr...

60 Degrees and Yale to progress tafenoquin for babesiosis

60 Degrees has signed a patent licence agreement with Yale School of Medicine fo...

Pharma CEOs warn EC President of “risk of exodus” to US

Pharma CEOs have told EC President von der Leyen they may shift operations towar...